Drugs / BLOOD, WHOLE
BLOOD, WHOLE
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 33 trials · 1 missed | ||||||
| Phase 3 | NCT05634109 | Jan 2023 → Dec 2025 overdue | — | Fundacion Clinica Valle del Lili | Recruiting | No outcome recorded |
| Phase 3 | NCT04431999 | Dec 2021 → Oct 2025 | blood coagulation disease | Central Directorate of the Army Health Service | Completed | No outcome recorded |
| Phase 3 | NCT03477006 | Nov 2018 → Oct 2020 | — | Jason Sperry | Terminated | Missed primary Stop: Enrollment |
| Phase not applicable1 trial | ||||||
| — | NCT06495294 | Dec 2024 → Dec 2026 expected | — | Unity Health Toronto | Recruiting | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 2 | NCT03981484 Comparator | Jan 2020 → Oct 2022 | blood coagulation disease, hemorrhagic disease | Bellal A. Joseph, MD, FACS | Unknown | No outcome recorded |
| Phase 3 | NCT04704869 Background | Jan 2017 → Dec 2021 | — | Bryan Cotton | Completed | Missed primary |
| Phase 4 | NCT02978833 Comparator | Oct 2013 → Jun 2017 | tendinosis | Hospital for Special Surgery, New York | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BLOOD, WHOLE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108414 ↗ |
| Known as | LTLR-WB | “University of Pittsburgh is currently utilizing cold stored, low titer, platelet replete-leukocyte reduced, group O whole blood (LTLR-WB) for urgent release in the emergency department” NCT03477006 ↗ |
| Known as | LTOWB | “Low titer group O whole blood (LTOWB) resuscitation is increasingly common in both military and civilian settings.” PMID 35081595 ↗ Jan 2022 |
| Known as | Whole Blood | “Randomization can assign participants to the experimental arm, transfusing them with 3 units of whole blood.” NCT05634109 ↗ |
| Modality | Other / unclassified | “Biological: Transfusion of blood products” NCT05634109 ↗ |
| Route | Intravenous | “Patients will be administered up to 2 units of whole blood administered via either intravenous (IV) or intraosseous (IO) route, according to standard practice at Ornge AAS.” NCT06495294 ↗ |
| Route | Other | “Patients will be administered up to 2 units of whole blood administered via either intravenous (IV) or intraosseous (IO) route, according to standard practice at Ornge AAS.” NCT06495294 ↗ |